Total Payments
$4,675
2024 Payments
$288.12
Companies
20
Transactions
206
Medicare Patients
16,991
Medicare Billing
$922,614
Payment Breakdown by Category
Food & Beverage$4,580 (98.0%)
Education$95.09 (2.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,580 | 203 | 98.0% |
| Education | $95.09 | 3 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,524 | 71 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $681.18 | 26 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $439.23 | 16 | $0 (2024) |
| GENZYME CORPORATION | $438.64 | 16 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $340.49 | 10 | $0 (2023) |
| PFIZER INC. | $317.58 | 17 | $0 (2024) |
| Lilly USA, LLC | $241.66 | 9 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $126.43 | 6 | $0 (2023) |
| Dermavant Sciences, Inc. | $122.43 | 8 | $0 (2024) |
| Janssen Biotech, Inc. | $118.37 | 6 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $288.12 | 16 | ABBVIE INC. ($80.94) |
| 2023 | $1,679 | 66 | ABBVIE INC. ($368.46) |
| 2022 | $1,536 | 66 | ABBVIE INC. ($665.71) |
| 2021 | $1,171 | 58 | AbbVie Inc. ($409.22) |
All Payment Transactions
206 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/28/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: IMMUNOLOGY | ||||||
| 03/27/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $24.35 | General |
| Category: Immunology | ||||||
| 03/21/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: DERMATOLOGY | ||||||
| 03/20/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: DERMATOLOGY | ||||||
| 03/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: IMMUNOLOGY | ||||||
| 03/06/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $25.01 | General |
| Category: Dermatology | ||||||
| 02/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: IMMUNOLOGY | ||||||
| 02/22/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: DERMATOLOGY | ||||||
| 02/20/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: IMMUNOLOGY | ||||||
| 02/15/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $27.59 | General |
| Category: Dermatology | ||||||
| 02/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | CYLTEZO (Biological) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: CNS | ||||||
| 02/01/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: DERMATOLOGY | ||||||
| 01/23/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: Dermatology | ||||||
| 01/23/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: IMMUNOLOGY | ||||||
| 01/16/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: Immunology | ||||||
| 01/05/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $7.94 | General |
| 12/16/2023 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: Immunology | ||||||
| 12/14/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.66 | General |
| Category: IMMUNOLOGY | ||||||
| 12/07/2023 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: DERMATOLOGY | ||||||
| 12/06/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $27.95 | General |
| Category: Dermatology | ||||||
| 11/30/2023 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $36.78 | General |
| Category: Immunology | ||||||
| 11/29/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: IMMUNOLOGY | ||||||
| 11/29/2023 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $16.61 | General |
| Category: Dermatology | ||||||
| 11/27/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $20.89 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 3,829 | 8,089 | $367,618 | $201,457 |
| 2022 | 19 | 4,064 | 9,341 | $408,200 | $231,028 |
| 2021 | 18 | 4,242 | 10,143 | $412,306 | $241,135 |
| 2020 | 22 | 4,856 | 11,993 | $440,586 | $248,995 |
Total Patients
16,991
Total Services
39,566
Medicare Billing
$922,614
Procedure Codes
78
All Medicare Procedures & Services
78 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 818 | 1,001 | $88,384 | $49,488 | 56.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 420 | 487 | $60,763 | $32,758 | 53.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 797 | 922 | $60,717 | $29,938 | 49.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 712 | 4,469 | $29,464 | $18,013 | 61.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 239 | 246 | $27,349 | $15,635 | 57.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 236 | 260 | $25,908 | $14,847 | 57.3% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 133 | 154 | $25,443 | $14,175 | 55.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 165 | 165 | $18,244 | $9,388 | 51.5% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 52 | 57 | $7,354 | $4,593 | 62.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 56 | 56 | $9,053 | $4,500 | 49.7% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 12 | 12 | $2,856 | $1,740 | 60.9% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 20 | 21 | $2,497 | $1,526 | 61.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 32 | 38 | $1,862 | $1,225 | 65.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 38 | 39 | $2,139 | $1,056 | 49.4% |
| 69100 | Biopsy of ear | Office | 2023 | 26 | 26 | $2,442 | $1,015 | 41.6% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 11 | 11 | $1,340 | $716.14 | 53.5% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 21 | 23 | $1,276 | $580.84 | 45.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 30 | $452.06 | $219.70 | 48.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 28 | 72 | $77.08 | $43.74 | 56.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 594 | 707 | $89,056 | $50,561 | 56.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 732 | 924 | $82,301 | $46,515 | 56.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 850 | 1,018 | $67,319 | $34,548 | 51.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 781 | 5,369 | $35,973 | $22,407 | 62.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 310 | 342 | $34,629 | $20,273 | 58.5% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 131 | 155 | $26,082 | $14,917 | 57.2% |
About Linda Larsen, RN NP-C
Linda Larsen, RN NP-C is a Family healthcare provider based in Abilene, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1184705089.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Linda Larsen, RN NP-C has received a total of $4,675 in payments from pharmaceutical and medical device companies, with $288.12 received in 2024. These payments were reported across 206 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($4,580).
As a Medicare-enrolled provider, Larsen has provided services to 16,991 Medicare beneficiaries, totaling 39,566 services with total Medicare billing of $922,614. Data is available for 4 years (2020–2023), covering 78 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Abilene, TX
- Active Since 10/18/2006
- Last Updated 06/18/2008
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1184705089
Products in Payments
- SKYRIZI (Biological) $683.50
- RINVOQ (Biological) $607.06
- DUPIXENT (Biological) $492.15
- COSENTYX (Biological) $435.95
- TALTZ (Drug) $241.66
- ILUMYA (Biological) $230.95
- COSENTYX (Drug) $223.85
- Sotyktu (Drug) $223.58
- EUCRISA (Drug) $221.88
- HUMIRA (Biological) $195.01
- Ilumya (Biological) $136.28
- VTAMA (Drug) $122.43
- CIBINQO (Drug) $95.70
- TREMFYA (Drug) $91.57
- OPZELURA (Drug) $54.41
- Otezla (Drug) $27.23
- REMICADE (Biological) $26.80
- DUOBRII (Drug) $18.90
- CYLTEZO (Biological) $18.18
- Erivedge (Biological) $17.57
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Abilene
Sandra Flores, Np, NP
Family — Payments: $4,903
Family $4,903
Teresa Sowa, Np-C, NP-C
Family — Payments: $4,749
Family $4,749
Mrs. Kathryn Barton, Rn, Fnp-C, RN, FNP-C
Family — Payments: $4,681
Family $4,681
Holly Mansur, Fnp-C, FNP-C
Family — Payments: $4,086
Family $4,086
Rachel Brown, Aprn Fnp-C, APRN FNP-C
Family — Payments: $3,511
Family $3,511
Zarina Calingo, Np-C, NP-C
Family — Payments: $3,323
Family $3,323